TWO INTERNATIONAL PLACE,
BOSTON , MA, 02110
BOSTON , MA, 02110
Summary
The fund invests in companies around the world active in health science, production and distribution of medical products and drugs.
The investment process takes advantage of three contributing global trends; rising income, ageing population, and increasingly rapid innovation cycle. The fundamental research driven process looks for companies that are estimated to gain markets, developing new products that extends medical care to a new More
Link
Directors
Nov 1, 2023- Cynthia E. Frost
- Anchal Pachnanda
- Scott E. Wennerholm
- George J. Gorman
- Alan C. Bowser
- Mark R. Fetting
- Nancy A. Wiser
- Keith Quinton
- Valerie A. Mosley
- Susan J. Sutherland
- Marcus L. Smith
Chief Compliance Officer
- Richard F. Froio
Fund Manager(s)
Price
- 52-Week High/Low
- $17.05 - $13.4
- Turnover
- 32%
- Expense Ratio
- 1.43%
Company Name |
Holding |
| Eli Lilly & Co | 10.74 % |
| UnitedHealth Group Inc | 7.59 % |
| Novo Nordisk A/S | 7.04 % |
| AbbVie Inc | 5.24 % |
| AstraZeneca PLC | 4.98 % |
| Thermo Fisher Scientific Inc | 4.47 % |
| Danaher Corp | 3.81 % |
| Roche Holding AG | 3.75 % |
| Intuitive Surgical Inc | 3.69 % |
| Johnson & Johnson | 3.35 % |
| More | 3.35 % |
Documents
Performance
YTD
-
3 Year
-5.85%
5 Year
22.9%
Best
44.06%
2013
Worst
-15.03%
2016
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 7.9% | -0.4% | -3.7% | 0.3% | -11.1% | 11.1% | -1.1% | 9.2% | -11.3% |
| Q2 | - | -4.8% | 3.3% | -7.5% | 9.2% | 14.1% | 1.7% | 6.6% | 5.4% | 3.7% |
| Q3 | - | - | -3.2% | -8.8% | -6.5% | -1.9% | -2.1% | 11.4% | 2.6% | 0.1% |
| Q4 | - | - | 4.1% | 7% | 10.6% | 6.2% | 8% | -8.9% | -2.7% | -7.7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 2.5% | 3.3% | 1.9% | -5.7% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 5% | 3% | -13% | 13% | 6% | 20% | 6% | 16% | -15% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ERHSX | - | 5% | 3% | -13% | 13% | 6% | 20% | 6% | 16% | -15% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 5% | 3% | 8% | -14% | -11% | -9% | 12% | -4% | -25% |